There are 4 versions of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (4)

Short Titles

Short Titles - Senate

Short Titles as Passed Senate

American Medical Isotopes Production Act of 2011

Short Titles as Reported to Senate

American Medical Isotopes Production Act of 2011

Short Titles as Introduced

American Medical Isotopes Production Act of 2011

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to promote the production of molybdenum-99 in the United States for medical isotope production, and to condition and phase out the export of highly enriched uranium for the production of medical isotopes.


Actions Overview (3)

Date Actions Overview
11/17/2011Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(text: CR S7780-7782)
05/18/2011Committee on Energy and Natural Resources. Reported by Senator Bingaman with an amendment in the nature of a substitute. With written report No. 112-17.
01/25/2011Introduced in Senate

All Actions (17)

Date Chamber All Actions
12/02/2011HouseReferred to the Subcommittee on Energy and Environment.
Action By: Committee on Science, Space, and Technology
11/18/2011HouseReferred to the Subcommittee on Energy and Power.
Action By: Committee on Energy and Commerce
11/18/2011HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Science, Space, and Technology, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
11/18/2011HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Science, Space, and Technology, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
11/18/2011HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Science, Space, and Technology, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
11/18/2011-10:04amHouseReceived in the House.
11/18/2011SenateMessage on Senate action sent to the House.
11/17/2011SenatePassed Senate with an amendment by Unanimous Consent. (text: CR S7780-7782)
11/17/2011SenateS.Amdt.1223 Amendment SA 1223 agreed to in Senate by Unanimous Consent.
11/17/2011SenateS.Amdt.1223 Amendment SA 1223 proposed by Senator Levin for Senator Bingaman. (consideration: CR S7780; text: CR S7780) To improve the bill.
11/17/2011SenateMeasure laid before Senate by unanimous consent. (consideration: CR S7778-7782; text of measure as reported in Senate: CR S7778-7780)
05/18/2011SenatePlaced on Senate Legislative Calendar under General Orders. Calendar No. 53.
05/18/2011SenateCommittee on Energy and Natural Resources. Reported by Senator Bingaman with an amendment in the nature of a substitute. With written report No. 112-17.
04/12/2011SenateCommittee on Energy and Natural Resources. Ordered to be reported with an amendment in the nature of a substitute favorably.
02/01/2011SenateCommittee on Energy and Natural Resources. Hearings held. Hearings printed: S.Hrg. 112-4.
01/25/2011SenateRead twice and referred to the Committee on Energy and Natural Resources. (text of measure as introduced: CR S188-189)
01/25/2011SenateSponsor introductory remarks on measure. (CR S188, S189-191)

Cosponsors (1)

* = Original cosponsor
CosponsorDate Cosponsored
Sen. Murkowski, Lisa [R-AK]* 01/25/2011

Committees (4)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Related Documents
Senate Energy and Natural Resources01/25/2011 Referred to
02/01/2011 Hearings by
04/12/2011 Markup by
05/18/2011 Reported by S. Rept. 112-17
House Energy and Commerce11/18/2011 Referred to
House Energy and Commerce Subcommittee on Energy and Power11/18/2011 Referred to
House Science, Space, and Technology11/18/2011 Referred to
House Science, Space, and Technology Subcommittee on Energy and Environment12/02/2011 Referred to
House Budget11/18/2011 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Latest Summary (3)

There are 3 summaries for S.99. View summaries

Shown Here:
Passed Senate amended (11/17/2011)

American Medical Isotopes Production Act of 2011 - (Sec. 3) Directs the Secretary of Energy (DOE) to implement a technology-neutral program to evaluate and support projects for the production in the United States (except in certain circumstances without the use of highly enriched uranium) of significant quantities of molybdenum-99 for medical uses, implemented in cooperation with non-federal entities, whose costs shall be shared in accordance with certain cost sharing requirements of the Energy Policy Act of 2005.

Directs the Secretary to: (1) develop and update annually a program plan through public workshops; (2) use the Nuclear Science Advisory Committee to conduct annual reviews of progress in achieving program goals; and (3) implement a program to provide assistance for the development of fuels, targets, and processes for domestic molybdenum-99 production that do not use highly enriched uranium, and for commercial operations using them.

Requires the Secretary to establish a program to make low enriched uranium available, through lease contracts, for irradiation for molybdenum-99 production for medical uses.

Requires such contracts to provide for the producers of the molybdenum-99 to take title to and be responsible for the molybdenum-99 created by the irradiation, processing, or purification of uranium leased under this Act.

Requires the contracts to require the Secretary to: (1) retain responsibility for the final disposition of spent nuclear fuel created under this Act for medical isotopes production; and (2) take title to and be responsible for final disposition of radioactive waste created by the irradiation, processing, or purification of uranium leased under this Act for which the producer does not have access to a disposal path.

Requires the producer of the spent nuclear fuel and radioactive waste to characterize accurately, package appropriately, and transport the spent nuclear fuel and radioactive waste before its acceptance by DOE.

Prohibits the Secretary from exchanging uranium for specified services.

Deems radioactive material resulting from the production of medical isotopes that has been permanently removed from a reactor or subcritical assembly, and for which there is no further use, to be low-level radioactive waste if it is acceptable under federal requirements for disposal as low-level radioactive waste.

(Sec. 4) Amends the Atomic Energy Act of 1954 to: (1) prohibit the Nuclear Regulatory Commission (NRC) from issuing a license for the export of highly enriched uranium from the United States, beginning seven years after enactment of this Act; and (2) authorize an extension of this seven-year period for up to another six years if the Secretary makes specified certifications to certain congressional committees.

Permits suspension of the export license restriction for a 12-month period if: (1) there is a critical shortage of molybdenum-99 to satisfy domestic U.S. medical isotope needs, (2) the Secretary certifies to Congress that the export of U.S.-origin highly enriched uranium for medical isotope production is the only effective temporary means to increase the supply of molybdenum-99 necessary to meet U.S. medical isotope needs during that period, and (3) Congress enacts a joint resolution approving the temporary suspension of such export license restriction.

(Sec. 5) Requires the NRC Chairman to report to Congress on the current disposition of previous US exports of highly enriched uranium used as fuel or targets in a nuclear research or test reactor.

(Sec. 6) Amends the Atomic Energy Act of 1954 to authorize the NRC to issue a license, or grant an amendment to an existing license, for use in the United States of highly enriched uranium as a target for medical isotope production in a nuclear reactor, but only if specified conditions are met, including certification by the Secretary that the federal government is actively supporting development of an alternative medical isotope production target that can be used in that reactor.

(Sec. 7) Directs the Secretary to report to Congress annually for five years on DOE actions to support U.S. production of molybdenum-99 for medical uses without the use of highly enriched uranium.

(Sec. 8) Instructs the Secretary to arrange with the National Academy of Sciences to study the state of molybdenum-99 production and utilization.

(Sec. 9) Repeals the Nuclear Safety Research, Development, and Demonstration Act of 1980.